ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,768 | -11.1% | 324,445 | +9.5% | 0.08% | -4.6% |
| Q2 2023 | $1,988 | -39.0% | 296,245 | -19.7% | 0.09% | -43.5% |
| Q1 2023 | $3,258 | +45.8% | 368,995 | +26.2% | 0.15% | +24.2% |
| Q4 2022 | $2,234 | -99.9% | 292,357 | +25.1% | 0.12% | +22.8% |
| Q3 2022 | $1,664,000 | -29.5% | 233,748 | -19.8% | 0.10% | -42.9% |
| Q2 2022 | $2,359,000 | +54.6% | 291,535 | +165.1% | 0.18% | +77.0% |
| Q1 2022 | $1,526,000 | – | 109,976 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |